{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:10:36Z","timestamp":1790010636204,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM075770"],"award-info":[{"award-number":["T32GM075770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10549-026-08078-1","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:40:57Z","timestamp":1790008857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Equivalent survival in targeted axillary dissection compared to axillary lymph node dissection in patients with node positive breast cancer receiving neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-1782","authenticated-orcid":false,"given":"Callie","family":"Hlavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle R.","family":"Lavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Cowher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Lupinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratulain","family":"Sabih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Steiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla F.","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia J.","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"8078_CR1","doi-asserted-by":"publisher","unstructured":"Kell MR, Burke JP, Barry M, Morrow M Outcome of axillary staging in early breast cancer: a meta-analysis. https:\/\/doi.org\/10.1007\/s10549-009-0705-6","DOI":"10.1007\/s10549-009-0705-6"},{"issue":"3","key":"8078_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0B013E3181F08F32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American college of surgeons oncology group z0011 randomized trial. Ann Surg 252(3):426\u2013432. https:\/\/doi.org\/10.1097\/SLA.0B013E3181F08F32","journal-title":"Ann Surg"},{"issue":"8","key":"8078_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMOA020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567\u2013575. https:\/\/doi.org\/10.1056\/NEJMOA020128","journal-title":"N Engl J Med"},{"issue":"9503","key":"8078_CR4","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087\u20132106. https:\/\/doi.org\/10.1016\/S0140-6736(05)67887-7","journal-title":"Lancet"},{"issue":"3","key":"8078_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00000658-199309000-00013","volume":"218","author":"C Blake","year":"1993","unstructured":"Blake C, Stone M, Wayne J (1993) New Therapeutic Possibilities in Primary Invasive Breast Cancer. Ann Surg 218(3):338\u2013349","journal-title":"Ann Surg"},{"issue":"1","key":"8078_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.SLA.0000167759.15670.14","volume":"242","author":"G Martelli","year":"2005","unstructured":"Martelli G, Boracchi P, De Palo M et al (2005) A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Ann Surg 242(1):1\u20136. https:\/\/doi.org\/10.1097\/01.SLA.0000167759.15670.14","journal-title":"Ann Surg"},{"issue":"5","key":"8078_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/BJS.5209","volume":"93","author":"Y Xing","year":"2006","unstructured":"Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93(5):539\u2013546. https:\/\/doi.org\/10.1002\/BJS.5209","journal-title":"Br J Surg"},{"issue":"1","key":"8078_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","volume":"230","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Sahin AA, Hunt KK et al (1999) Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230(1):72\u201378. https:\/\/doi.org\/10.1097\/00000658-199907000-00011","journal-title":"Ann Surg"},{"issue":"8","key":"8078_CR9","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16(8):2672\u20132685. https:\/\/doi.org\/10.1200\/JCO.1998.16.8.2672","journal-title":"J Clin Oncol"},{"issue":"8","key":"8078_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/BF02303476","volume":"5","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Fornage BD et al (1998) Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 5(8):673\u2013680. https:\/\/doi.org\/10.1007\/BF02303476","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"8078_CR11","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1245\/S10434-012-2484-2","volume":"19","author":"R Alvarado","year":"2012","unstructured":"Alvarado R, Yi M, Le-Petross H et al (2012) The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177\u20133184. https:\/\/doi.org\/10.1245\/S10434-012-2484-2","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"8078_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1148\/RADIOL.10100296","volume":"257","author":"CH Neal","year":"2010","unstructured":"Neal CH, Daly CP, Nees AV, Helvie MA (2010) Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? Radiology 257(2):335\u2013341. https:\/\/doi.org\/10.1148\/RADIOL.10100296","journal-title":"Radiology"},{"issue":"6","key":"8078_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/BJS.5338","volume":"93","author":"A Gil-Rendo","year":"2006","unstructured":"Gil-Rendo A, Zornoza G, Garc\u00eda-Velloso MJ, Regueira FM, Beorlegui C, Cervera M (2006) Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg 93(6):707\u2013712. https:\/\/doi.org\/10.1002\/BJS.5338","journal-title":"Br J Surg"},{"issue":"3","key":"8078_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.SLA.0000250439.86020.85","volume":"245","author":"J Park","year":"2007","unstructured":"Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS (2007) A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245(3):462\u2013468. https:\/\/doi.org\/10.1097\/01.SLA.0000250439.86020.85","journal-title":"Ann Surg"},{"issue":"36","key":"8078_CR15","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23(36):9304\u20139311. https:\/\/doi.org\/10.1200\/JCO.2005.02.5023","journal-title":"J Clin Oncol"},{"issue":"7","key":"8078_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609\u2013618. https:\/\/doi.org\/10.1016\/S1470-2045(13)70166-9","journal-title":"Lancet Oncol"},{"issue":"14","key":"8078_CR17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/JAMA.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455\u20131461. https:\/\/doi.org\/10.1001\/JAMA.2013.278932","journal-title":"JAMA"},{"issue":"3","key":"8078_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 33(3):258\u2013263. https:\/\/doi.org\/10.1200\/JCO.2014.55.7827","journal-title":"J Clin Oncol"},{"issue":"2","key":"8078_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/S10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P et al (2019) Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat 173(2):343\u2013352. https:\/\/doi.org\/10.1007\/S10549-018-5004-7","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"8078_CR20","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694\u20132702. https:\/\/doi.org\/10.1200\/JCO.2005.05.188","journal-title":"J Clin Oncol"},{"key":"8078_CR21","unstructured":"NCCN clinical practice guidelines in oncology: breast cancer. version 4.2023. Published March 23 (2023) Accessed March 30, 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"4","key":"8078_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT et al (2016) Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg 263(4):802\u2013807. https:\/\/doi.org\/10.1097\/SLA.0000000000001375","journal-title":"Ann Surg"},{"issue":"10","key":"8078_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S et al (2016) Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072\u20131078. https:\/\/doi.org\/10.1200\/JCO.2015.64.0094","journal-title":"J Clin Oncol"},{"issue":"5","key":"8078_CR24","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1245\/S10434-015-5052-8","volume":"23","author":"EJ Diego","year":"2016","unstructured":"Diego EJ, McAuliffe PF, Soran A et al (2016) Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes. Ann Surg Oncol 23(5):1549\u20131553. https:\/\/doi.org\/10.1245\/S10434-015-5052-8","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"8078_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J et al (2015) Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg 261(2):378\u2013382. https:\/\/doi.org\/10.1097\/SLA.0000000000000558","journal-title":"Ann Surg"},{"issue":"6","key":"8078_CR26","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1245\/S10434-011-2199-9","volume":"19","author":"MC Lee","year":"2012","unstructured":"Lee MC, Plews R, Rawal B, Kiluk JV, Loftus L, Laronga C (2012) Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol 19(6):1818\u20131824. https:\/\/doi.org\/10.1245\/S10434-011-2199-9","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"8078_CR27","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1245\/S10434-023-13759-Y","volume":"30","author":"JC Boughey","year":"2023","unstructured":"Boughey JC, Yu H, Dugan CL et al (2023) Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol 30(11):6401\u20136410. https:\/\/doi.org\/10.1245\/S10434-023-13759-Y","journal-title":"Ann Surg Oncol"},{"key":"8078_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/J.BREAST.2016.11.012","volume":"31","author":"L Schwentner","year":"2017","unstructured":"Schwentner L, Helms G, Nekljudova V et al (2017) Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial. Breast 31:202\u2013207. https:\/\/doi.org\/10.1016\/J.BREAST.2016.11.012","journal-title":"Breast"},{"issue":"10","key":"8078_CR29","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1245\/S10434-017-5958-4","volume":"24","author":"AS Caudle","year":"2017","unstructured":"Caudle AS, Bedrosian I, Milton DR et al (2017) Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol 24(10):2925\u20132934. https:\/\/doi.org\/10.1245\/S10434-017-5958-4","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"8078_CR30","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1245\/S10434-022-11866-W","volume":"29","author":"C Tinterri","year":"2022","unstructured":"Tinterri C, Gentile D, Gatzemeier W et al (2022) Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial. Ann Surg Oncol 29(9):5732\u20135744. https:\/\/doi.org\/10.1245\/S10434-022-11866-W","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"8078_CR31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/JAMASURG.2022.3907","volume":"157","author":"JM Simons","year":"2022","unstructured":"Simons JM, Van Nijnatten TJA, Van Der Pol CC et al (2022) Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. JAMA Surg 157(11):991. https:\/\/doi.org\/10.1001\/JAMASURG.2022.3907","journal-title":"JAMA Surg"},{"issue":"9","key":"8078_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/S00432-017-2425-3","volume":"143","author":"F Ebner","year":"2017","unstructured":"Ebner F, W\u00f6ckel A, Janni W, Kreienberg R, Schwentner L, Wischnewsky M (2017) Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival. J Cancer Res Clin Oncol 143(9):1823\u20131831. https:\/\/doi.org\/10.1007\/S00432-017-2425-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"8078_CR33","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/S00520-018-4186-1","volume":"26","author":"R Belmonte","year":"2018","unstructured":"Belmonte R, Messaggi-Sartor M, Ferrer M, Pont A, Escalada F (2018) Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB. Support Care Cancer 26(9):3277\u20133287. https:\/\/doi.org\/10.1007\/S00520-018-4186-1","journal-title":"Support Care Cancer"},{"issue":"12","key":"8078_CR34","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1200\/JCO.22.01565","volume":"41","author":"SAL Bartels","year":"2023","unstructured":"Bartels SAL, Donker M, Poncet C et al (2023) Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981\u201322023 AMAROS Trial. J Clin Oncol 41(12):2159\u20132165. https:\/\/doi.org\/10.1200\/JCO.22.01565","journal-title":"J Clin Oncol"},{"issue":"3","key":"8078_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamasurg.2024.5913","volume":"160","author":"N Cab\u0131o\u011flu","year":"2025","unstructured":"Cab\u0131o\u011flu N, Ko\u00e7er HB, Karanl\u0131k H et al (2025) De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer. JAMA Surg 160(3):257\u2013266. https:\/\/doi.org\/10.1001\/jamasurg.2024.5913","journal-title":"JAMA Surg"},{"key":"8078_CR36","doi-asserted-by":"publisher","unstructured":"K\u00fchn T, Banys-Paluchowski M, Ditsch N, AXSANA study group (2026) More versus less invasive axillary surgical staging procedures in breast cancer patients converting from a clinically node-positive to a clinically node-negative stage through neoadjuvant chemotherapy - primary endpoint analysis of the international prospective multicenter AXSANA\/EUBREAST 3(R)study. Clin Cancer Res 15(4Supplement):GS2\u2013G01. https:\/\/doi.org\/10.1158\/1557-3265.SABCS25-GS2-01","DOI":"10.1158\/1557-3265.SABCS25-GS2-01"},{"key":"8078_CR37","unstructured":"Tailored Axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS) - Full Text View - ClinicalTrials.gov. Accessed November 2 (2023) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03513614"},{"key":"8078_CR38","unstructured":"Comparison of Axillary Lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy | ClinicalTrials.gov. Accessed November 2 (2023) https:\/\/clinicaltrials.gov\/study\/NCT01901094"},{"key":"8078_CR39","unstructured":"Standard or comprehensive radiation therapy in treating patients with early-stage breast cancer previously treated with chemotherapy and surgery - full text view - ClinicalTrials.gov. Accessed November 2 (2023) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01872975"},{"key":"8078_CR40","unstructured":"Axillary management in breast cancer patients with needle biopsy proven nodal metastases after Neoadjuvant Chemotherapy | ClinicalTrials.gov. Accessed November 2 (2023) https:\/\/clinicaltrials.gov\/study\/NCT04109079"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08078-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:40:59Z","timestamp":1790008859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08078-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8078"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08078-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Pittsburgh institutional review board reviewed and approved this study (STUDY19030445). Informed consent of study participants was waived because it was deemed to present no more than minimal risk of harm to patients.","order":1,"name":"Ethics","label":"Ethical approvel","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"18"}}